Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-002738
Filing Date
2022-03-08
Accepted
2022-03-08 16:06:04
Documents
1
Period of Report
2022-03-07

Document Format Files

Seq Description Document Type Size
1 form4-03082022_040339.html 4  
1 form4-03082022_040339.xml 4 4088
  Complete submission text file 0001415889-22-002738.txt   5375
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 BOYLSTON ST., 2ND FLOOR BOSTON MA 02116
Business Address
Namouni Fouad (Reporting) CIK: 0001815851 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 22721730